Altamira Therapeutics Ltd. (CYTOF) — key financial figures for fiscal year 2024 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Net Income/Loss (FY2024)

-$8.5M

Total Assets (FY2024)

$8.7M

Total Equity (FY2024)

$6.6M

Cash Flows from Operating Activities (FY2024)

-$6.1M

Source: Altamira Therapeutics Ltd. 20-F filing (FY2024). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.